topotecan has been researched along with matrine, (5beta)-isomer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bi, CW; Deng, HB; Li, YH; Shao, RG; Song, DQ; Tang, S; Wang, Z; Zhang, CX; Zhao, WL | 1 |
1 other study(ies) available for topotecan and matrine, (5beta)-isomer
Article | Year |
---|---|
Novel N-substituted sophoridinol derivatives as anticancer agents.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HCT116 Cells; Hep G2 Cells; Humans; Injections, Intravenous; KB Cells; Male; MCF-7 Cells; Mice; Mice, Inbred ICR; Models, Molecular; Molecular Structure; Quinazolines; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Topoisomerase I Inhibitors | 2014 |